Assessing eligibility for non-intensive chemotherapy (IC) randomized clinical trials (RCT) in patients (pts) with newly diagnosed (ND) AML from the Connect Myeloid Disease Registry.
Publication
, Conference
Erba, HP; Pollyea, DA; Sekeres, MA; Garcia-Manero, G; Seiter, K; DeGutis, I; Kiselev, P; McBride, A; Yu, E; Roboz, GJ
Published in: JOURNAL OF CLINICAL ONCOLOGY
2022
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2022
Volume
40
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Erba, H. P., Pollyea, D. A., Sekeres, M. A., Garcia-Manero, G., Seiter, K., DeGutis, I., … Roboz, G. J. (2022). Assessing eligibility for non-intensive chemotherapy (IC) randomized clinical trials (RCT) in patients (pts) with newly diagnosed (ND) AML from the Connect Myeloid Disease Registry. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 40).
Erba, Harry Paul, Daniel Aaron Pollyea, Mikkael A. Sekeres, Guillermo Garcia-Manero, Karen Seiter, Irene DeGutis, Pavel Kiselev, Ali McBride, Edward Yu, and Gail J. Roboz. “Assessing eligibility for non-intensive chemotherapy (IC) randomized clinical trials (RCT) in patients (pts) with newly diagnosed (ND) AML from the Connect Myeloid Disease Registry.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 40, 2022.
Erba HP, Pollyea DA, Sekeres MA, Garcia-Manero G, Seiter K, DeGutis I, et al. Assessing eligibility for non-intensive chemotherapy (IC) randomized clinical trials (RCT) in patients (pts) with newly diagnosed (ND) AML from the Connect Myeloid Disease Registry. In: JOURNAL OF CLINICAL ONCOLOGY. 2022.
Erba, Harry Paul, et al. “Assessing eligibility for non-intensive chemotherapy (IC) randomized clinical trials (RCT) in patients (pts) with newly diagnosed (ND) AML from the Connect Myeloid Disease Registry.” JOURNAL OF CLINICAL ONCOLOGY, vol. 40, no. 16, 2022.
Erba HP, Pollyea DA, Sekeres MA, Garcia-Manero G, Seiter K, DeGutis I, Kiselev P, McBride A, Yu E, Roboz GJ. Assessing eligibility for non-intensive chemotherapy (IC) randomized clinical trials (RCT) in patients (pts) with newly diagnosed (ND) AML from the Connect Myeloid Disease Registry. JOURNAL OF CLINICAL ONCOLOGY. 2022.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2022
Volume
40
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences